As a result of these fusion mutations, high levels of RSPO2 and RSPO3 are detected in tumours harbouring these mutations [50,51], and indeed, mice harbouring Rspo2 or Rspo3 fusion mutations develop intestinal tumours [52]. This evidence concerns the gene RSPO3 and neoplasm.